MARKET

LGNDZ

LGNDZ

Ligand Pharma
OTCPK
0.0035
NaN%
Closed 09:30 01/16 EST
OPEN
--
PREV CLOSE
0.0068
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.013
52 WEEK LOW
0.0006
MARKET CAP
--
P/E (TTM)
0.0017
1D
5D
1M
3M
1Y
5Y
1D
Ligand Pharmaceuticals Incorporated - Equity Right (LGNDZ) Price Target Increased by 23.15% to 0.01
NASDAQ · 12/21/2025 13:24
Ligand Pharmaceuticals Incorporated - Equity Right (LGNDZ) Price Target Increased by 11.39% to 0.01
NASDAQ · 12/06/2025 01:27
Ligand Pharmaceuticals Incorporated - Equity Right (LGNDZ) Price Target Increased by 47.34% to 0.01
NASDAQ · 11/09/2025 04:59
Weekly Report: what happened at LGNDZ last week (0908-0912)?
Weekly Report · 09/15/2025 11:56
Weekly Report: what happened at LGNDZ last week (0901-0905)?
Weekly Report · 09/08/2025 11:58
Weekly Report: what happened at LGNDZ last week (0825-0829)?
Weekly Report · 09/01/2025 11:52
Weekly Report: what happened at LGNDZ last week (0818-0822)?
Weekly Report · 08/25/2025 12:06
Weekly Report: what happened at LGNDZ last week (0811-0815)?
Weekly Report · 08/18/2025 11:56
More
About LGNDZ
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including OTCPK: LGNDZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGNDZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGNDZ stock methods without spending real money on the virtual paper trading platform.